NAICS 541714in54171:Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in Biotechnology (except Nanobiotechnology)

55 active contract opportunities

Oportunidades Activas

Publicadas Últimos 7 Días

30 días

Ventana de Respuesta Prom.

Principales Industrias

Research and Development in Biotechnology (except Nanobiotechnology)55

Distribución de Reservas

37
No Set Aside12
Small Business4
8(a) Competed1
8(a) Sole Source1

Principales Ubicaciones

MD22
DC14
VA10
OH2
WA2

About NAICS541714

The North American Industry Classification System (NAICS) code 541714 covers research and development in biotechnology (except nanobiotechnology). Federal agencies use NAICS codes to classify contracts by industry. Businesses should register their applicable NAICS codes in SAM.gov.

SAM.gov Registration →|Set-Aside Programs →

Related Industries

541110:Offices of Lawyers 541120:Offices of Notaries 541191:Title Abstract and Settlement ...541199:All Other Legal Services 541211:Offices of Certified Public Ac...541213:Tax Preparation Services

Research and Development in Biotechnology (except Nanobiotechnology)

Principales Industrias

Distribución de Reservas

Principales Ubicaciones

About NAICS541714

Related Industries

Future Program: Fleetwood

Protean

66-NOTICE OF INTENT

6515-SOURCES SOUGHT - 3D Bioprinter for Research Project for the Iowa City VA Healthcare System

AN11-Intent to Sole Source MRI Scanning and Image Analysis

BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI)

Compact Oxygen Generation Medical Devices: Compact Oxygen Generation, Medical (COGM) and Compact Oxygen Generation, Medical At Altitude (COGM-A)

Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Innovative Solutions Opening (ISO)

Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract

FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

NAWCWD Broad Agency Announcement

Generative Optogenetics (GO)

FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

A-NIH NeuroBioBank Brain and Tissue Repository

A-NIH NeuroBioBank Brain and Tissue Repository

Policy Working Group for Switch Biomanufacturing

Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains

Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

GENETIC MEDICINES AND INDIVIDUALIZED MANUFACTURING FOR EVERYONE (GIVE)

Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection